ore than 90% of patients with congenital heart disease (CHD) survive to adulthood in developed countries, including Japan. 1-5 As a result, pregnancy and delivery-associated complications are assuming major importance in the health care of women with congenital heart disease (WCHD), especially those with severe forms of CHD. Dynamic cardiovascular adaptations as well as neurohormonal changes accompany pregnancy and put significant additional demands on the cardiovascular system. The initial adaptation during the first trimester is a 40-70% decline in total peripheral vascular resistance combined with low vascular resistance in the placenta and uterus, which cause a relatively underfilled vascular status, resulting in 30-50% plasma volume increase until gestational week 34. Furthermore, additional cardiac venous return due to post-delivery uterine contractions together with a decompression of the inferior caval vein causes an additional increase in cardiac output. 6-10 Thus, these dynamic adaptations increase the risk of adverse maternal and neonatal events especially in women with severe CHD. Low functional capacity, that is, higher New York Heart Association (NYHA) class, is a robust predictor of adverse pregnancy outcome. 11 A recent multicenter study demonstrated that impaired heart rate (HR) response during exercise testing was another important predictor. 12 The association of NYHA class and exercise HR response with adverse pregnancy outcome indicates a significant relationship between maternal aerobic exercise capacity and pregnancy outcome. The exact relationship, however, remains unclear, so objective referent exercisederived values are not able to be used with regard to these expectant women. 12 Accordingly, the aim of the present study was twofold: first to reconfirm a significant association of exercise capacity with pregnancy outcome; and second, to determine objective referent cardiopulmonary variables by cardiopulmonary exercise testing (CPX) for practical use in ensuring safer pregnancy in WCHD.
Exercise Variables and Pregnancy in CHD

Methods
Subjects
We retrospectively reviewed all WCHD at the time of CPX between January 2000 and December 2010 at the exercise laboratory and identified 33 WCHD who had experienced pregnancies and/or deliveries with an interval of ≤6.0 years after the last CPX. Of those, 17 WCHD experienced ≥2 pregnancies, including 3 pregnancies in 1 patient. The clinical characteristics of these 33 patients are listed in Table 1 . Fifteen age-matched female volunteers participated in this study to provide normal CPX derived values.
Exercise Protocol
All subjects underwent symptom-limited treadmill exercise using a ramp protocol; endurance time, V O2 at anaerobic threshold and peak exercise were measured. 13 A 12-lead electrocardiogram was used to determine HR. Systolic blood pressure was measured by palpation at rest and at peak exercise owing to the difficulty in measuring blood pressure with a mercury sphygmomanometer during exercise. In a preliminary study, systolic blood pressure obtained by this method in 12 children with cardiac disease correlated with measurements taken with a mercury sphygmomanometer (r=0.98, P<0.0001). Ventilation and gas exchange were measured using a breathby-breath method. The subjects breathed through a mask connected to a hot-wire anemometer (Riko AS500, Minato Medical Science, Osaka, Japan) to measure inspired and expired volume and a mass spectrometer (MG-300, Perkins Elmer, St Louis, MO, USA) was used to measure oxygen and carbon dioxide partial pressures continuously. Minute ventilation and respiratory rate were measured, and ventilatory equivalents for oxygen and carbon dioxide and respiratory gas exchange ratio were computed in real time and displayed with the HR and V O2 on a monitor. Anaerobic threshold was determined by the V-slope method 14 and chronotropic index was also calculated as follows: (peak HR -resting HR) / (220 -age -resting HR).
Arrhythmias During CPX
Clinically relevant exercise-induced arrhythmias were identified as those including ≥2 forms of premature ventricular contraction, ≥couplets for atrial and/or ventricular arrhythmias, and transient frequent arrhythmias including bigeminy. 15 Maternal Cardiac, Obstetric, and Neonatal Outcome Maternal cardiac complications were subdivided into primary and secondary events as described previously. 11 Primary maternal cardiac outcomes included heart failure, which was considered to be present if there were symptoms either at rest or on exercise with objective evidence of cardiac dysfunction and/or a response to treatment. Other maternal cardiac adverse events included sustained tachyarrhythmia or bradyarrhythmia requiring treatment, cardiac arrest, stroke, or death. Secondary maternal cardiac outcomes included decline in NYHA class by 2 classes, need for urgent invasive cardiac intervention during pregnancy or within 6 weeks postpartum, or symptomatic non-sustained tachyarrhythmia or bradyarrhythmia requiring therapy. Maternal obstetric outcomes included non-cardiac death, pre-eclampsia, or postpartum hemorrhage. Neonatal outcomes included miscarriage (≥16 weeks gestation), premature birth (<37 weeks gestation), small for gestational age birth weight (<10 th percentile), fetal death (≥16 weeks gestation), neonatal death (<1 month of birth), respiratory distress syndrome, or intraventricular hemorrhage.
Statistical Analysis
Descriptive data are expressed as mean ± SD. Comparisons between 2 groups were carried out with 2-sided t-tests for continuous variables. We used simple regression analysis to determine correlations between continuous parameters obtained. Logistic regression analysis was used to identify potential risk factors for any cardiac, neonatal, and cardiac and/or neonatal event. When the variables were statistically significant, we used receiver operating characteristic (ROC) curve analysis to determine cut-offs that could meaningfully predict the probability of maternal and/or neonatal events, that is, the values with a maximum area under the curve (AUC). Statistical analysis was performed using JMP 6 (SAS Institute, Cary, NC, USA). Data given as mean ± SD or n (%). † Unoperated patients. AVR, atrioventricular valve regurgitation; NYHA, New York Heart Association.
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P<0.05 was considered significant.
Results
Maternal Clinical Characteristics
Clinical characteristics of the study patients are listed in Table 1 . Thirty-one had undergone a biventricular repair, 1 had had a Fontan operation and 1 had palliative surgery for Eisenmenger syndrome. Three women with unrepaired atrial septal defect and 2 with aortic valve stenosis were also included. A balloon angioplasty had been applied in 1 woman with aortic valve stenosis before the pregnancy. Medication(s) were prescribed in 8 (24%) and angiotensin-converting enzyme inhibitor had been discontinued at the time of the pregnancy.
CPX Variables During Exercise Testing
Results of CPX before pregnancy are summarized in Table 2 .
The interval from CPX to delivery (miscarriage in 1) was 1.8±2.2 years and the peak respiratory gas exchange ratio was 1.19±0.07, indicating maximum exercise effort during CPX. When compared with normal volunteers, exercise time, peak HR, V O2 at anaerobic threshold and peak exercise were significantly lower (P<0.01-0.001) in the WCHD despite there being no difference in the peak respiratory gas exchange ratio. Clinically relevant exercise-induced arrhythmias were seen in 7 WCHD (21%).
Prevalence of Maternal Cardiac, Obstetric and Neonatal Events
The pregnancy outcomes are given in Table 3 . Fourteen deliveries were by cesarean section and for this group the gestational age was shorter (37±4 weeks) and birth weight lower (2,693±534 g) than for normal delivery. Maternal cardiac events occurred in 8 (24%), including heart failure in 4, arrhythmia in 1 and heart failure with arrhythmia in 3. Neonatal events occurred in 12 pregnancies (36%), including fetal distress in a woman with tetralogy of Fallot with pulmonary atresia and miscarriage at 17 weeks gestational age in the Fontan patient. Overall, 14 (42%) of the WCHD experienced either maternal and/or neonatal events. In contrast, postpartum hemorrhage was the main obstetric event, and included 1 placental abruption. No pregnancy-related hypertension was observed.
Impact of Gestational Age and Exercise Variables on Birth Weight
Although the gestational age at the time of delivery was closely associated with the birth weight, there was a trend for lower birth weight for gestational age ( Figure 1A) . The maternal NYHA class and all CPX variables, especially the exercise time, peak systolic blood pressure and peak V O2, had a significant impact on birth weight (P<0.005; Table 4 ; Figures 1B-D) .
Impact of Height, NYHA Class and Medication(s) on Maternal and Neonatal Events
The NYHA class had a significant impact on all the pregnancy outcomes. In addition, the use of medication(s) before pregnancy had a strong impact on the pregnancy outcomes and all the women on medication(s) before pregnancy experienced at least 1 adverse event(s). In contrast, body height had no impact on pregnancy outcome, including birth weight.
Impact of Exercise Variables on Maternal and Neonatal Events
Peak HR and V O2 were significantly lower in the WCHD with adverse pregnancy events, except for peak HR between the WCHD with and without neonatal events (Figure 2) . The impact of CPX variables is given in Table 4 . Maternal cardiac events were significantly associated with exercise time, HR, systolic blood pressure, and V O2 at peak exercise, while exer- 
Data given as mean ± SD or n (%). Exercise Variables and Pregnancy in CHD
cise time, V O2 at the anaerobic threshold and peak exercise, and the appearance of clinically relevant arrhythmia(s) were associated with neonatal events. Exercise time, peak HR, and V O2 at the anaerobic threshold and that at peak exercise were associated with maternal and/or neonatal events. Neither CPX variables nor NYHA class were associated with obstetric events.
CPX Cut-Off for Adverse Pregnancy Outcomes
According to ROC analysis, we determined the cut-off values of peak HR and V O2 for efficient prediction of the pregnancy outcomes. For peak HR, we determined a cut-off of 150 beats/ min for the maternal cardiac events (AUC=0.74) and maternal and/or neonatal events (AUC=0.77). Regarding the cut-offs for peak V O2, 22.0 ml · kg -1 · min -1 (AUC=0.82), 26.2 ml · kg -1 · min -1 (AUC=0.79) and 25.3 ml · kg -1 · min -1 (AUC=0.85) were the corresponding values for predicting maternal, neonatal, and maternal and/or neonatal events, respectively. In addition, 16.9 ml · kg -1 · min -1 (AUC=0.77) was the cut-off value of V O2 at the anaerobic threshold for the efficient prediction of the maternal and/or neonatal events.
Discussion
The present study has confirmed the strong association between maternal functional capacity, that is, NYHA class, and pregnancy outcomes in WCHD. Furthermore, to our knowledge, this is the first study to demonstrate a close correlation between objective values of aerobic capacity and pregnancy outcomes in WCHD. Heart failure (NYHA class III-IV, left ventricular ejection fraction [LVEF] <35-40%) has been 1 of several robust risk factors for pregnancy outcomes in WCHD. 16 Considering the weak correlation between LVEF 17 and peak V O2 and a significant discrepancy between subjective and objective assessments of postoperative status in adults with CHD, 18 tangible and objective CPX measurements are useful not only for physicians but also for WCHD who are pregnant. In addition, we have also demonstrated for the first time that maternal aerobic exercise capacity is associated with fetal growth. Because abnormal maternal cardiac function and morphology cause reduced placental perfusion and eventually result in fetal growth restriction, 19 limited cardiac reserve (reduced peak V O2) may be associated with frequent placental Figure 1 . Impact of (A) gestational age at delivery; (B) maternal peak heart rate (HR); (C) peak systolic blood pressure (SBP); and (D) peak oxygen uptake (V O2) on birth weight.
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hypoperfusion during daily life, ultimately causing fetal growth restriction. Nevertheless, according to the present results, in addition to the maternal NYHA class I, peak HR ≥150 beats/min (82% of normal) and/or peak V O2 ≥25 ml · kg -1 · min -1 (68% of normal) during CPX may be referent objective value(s) for a safer pregnancy outcome in WCHD, including appropriate fetal development. The other traditional risk factors include pulmonary hypertension (Eisenmenger syndrome), outflow tract stenosis (severe aortic stenosis with a mean pressure gradient >40-50 mmHg), Marfan syndrome (ascending aortic diameter at end-diastole >40 mm), mechanical valves, and cyanotic heart disease (arterial oxygen saturation <85%). 16 In the present study, we had 2 WCHD with NYHA class III (repaired tetralogy of Fallot with pulmonary atresia, patent ductus arteriosus with Eisenmenger syndrome), 1 with corrected transposition of the great arteries after conventional repair with low systemic ventricular ejection fraction <30%, and 1 with aortic valve stenosis (pressure gradient, 40 mmHg). All values of peak V O2 for those WCHD were <22.0 ml · kg -1 · min -1 , except for the woman with aortic valve stenosis (peak V O2=29.2 ml · kg -1 · min -1 , and all the women, except the aortic valve stenosis patient, experienced at least 1 adverse event. In contrast, all 5 WCHD with a peak V O2 <20 ml · kg -1 · min -1 had experienced at least 1 adverse pregnancy outcome, suggesting the importance of peak V O2 as a reference measure for safer pregnancy outcome in WCHD.
Prior cardiac events, including arrhythmia, are also important predictors of adverse pregnancy outcomes. 11 The current study has demonstrated that a history of medication(s) prior to pregnancy is strongly associated with obstetric outcomes. This may be due to confounding with prior cardiac history, explaining the higher risk of neonatal/maternal outcomes. Interestingly, clinically relevant arrhythmia(s) were associated with the neonatal events. Although the underlying mechanisms are unclear, frequent hemodynamic fluctuations due to arrhythmia might adversely affect fetal growth.
Study Limitations
The study had several limitations. First, the major limitation was the small number of WCHD included, which prevented multivariate analysis to identify reliable independent predictors for safer pregnancy outcome. In addition, a wide variety of diagnoses in the present patients may have had a significant impact on the associations of CPX-derived variables and pregnancy outcomes. For instance, the clinical meaning of peak HR for repaired patients may be different to that for unrepaired patients because the surgical procedure itself has a significant impact on peak HR. 20 In this respect, peak V O2 may be more valuable for predicting safer pregnancy outcome in WCHD with complex pathophysiologies because determinants for peak V O2 are multifactorial, including peak HR, respiratory function and working muscle metabolism. 21 Although the present results may not guarantee better fetal development in WCHD with preserved HR response and/or peak V O2, rather, we may have to emphasize a close association of impaired cardiopulmonary response during exercise with adverse pregnancy outcomes. Second, the retrospective nature could not clarify causal associations, especially for the relationships between CPX variables and birth weight because the timing of deliveries was sometimes decided based on obstetric reasons. In addition to hemodynamic issues, traditional risk factors for fetal growth need to be considered. Maternal genes, especially maternal height, which mainly determines uterine size, and nutrient intake are determinants of fetal development.
22-24
Although we did not check maternal nutritional issues, especially iron deficiency, 25 maternal height had no impact on fetal development, implying greater impact of impaired hemodynamics on fetal growth in WCHD. Third, objective CPX values may not be equivalent with regard to different types of CPX data, for instance, those obtained using bicycle exercise. Finally, the interval between CPX and the nearest pregnancy outcome varied significantly, indicating that the CPX values did not reflect the corresponding cardiopulmonary function at the time of pregnancy. A previous serial assessment of exercise capacity in adults with tetralogy of Fallot (mean age, 29±7 years), however, demonstrated no significant serial change in peak V O2 with a mean follow-up of 6.7 years. 15 Therefore, we speculate that the CPX values obtained 1.8±2.2 years before the following nearest delivery, to some extent, reflect the cardiopulmonary function at the time of pregnancy. Nevertheless, prospective large-scale studies, including comprehensive maternal environmental assessment, to confirm the present data are warranted.
Conclusions
CPX parameters of peak HR ≥150 beats/min and/or peak V O2 ≥25 ml · kg -1 · min -1 were found to be associated with pregnancy outcome in this study. Larger prospective studies are needed to determine whether these cut-offs for HR and peak V O2 may be reference values for safer pregnancy outcomes in WCHD. Comparisons of peak heart rate (HR) and peak oxygen uptake (V O2) in women with congenital heart disease (A) with and without maternal events and (B) with and without neonatal events.
